Ptc Therapeutics, Inc. (PTCT)
$38.49
Ptc Therapeutics, Inc. (PTCT) Share Price Forecast
Currently 20 wall-street analysts regularly analyze the financials of Ptc Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 20 analysts offering 12-month price forecasts for Ptc Therapeutics, Inc. (PTCT) have a share price target of $39. This median of share price forecast represents a 1.33% upside from the latest price of $38.49 as on 12.10.24.
Ptc Therapeutics, Inc. (PTCT) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Ptc Therapeutics, Inc. (PTCT) share price will touch around $39 in next 12-months.
Ptc Therapeutics, Inc. (PTCT) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Ptc Therapeutics, Inc.'s share price and its median forecast price. As on 12.10.24, the difference is -7.56%
Ptc Therapeutics, Inc. (PTCT): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Ptc Therapeutics, Inc. (PTCT) Share Price : Analyst Recommendation
Based on 20 analysts tracking and researching Ptc Therapeutics, Inc. (PTCT) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 3 | 3 | 6 |
| Outperform | 2 | 2 | 4 |
| Hold | 7 | 6 | 6 |
| Underperform | 3 | 3 | 1 |
| Sell | 5 | 5 | 3 |
Ptc Therapeutics, Inc. (PTCT) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Ptc Therapeutics, Inc. (PTCT) is $39, offered by 20 analysts offering 12-month price forecasts.
Ptc Therapeutics, Inc. (PTCT) has a maximum of 0.01 upside potential, based on 20 analysts offering 12-month price forecasts.
Based on 20 analysts tracking and researching Ptc Therapeutics, Inc. (PTCT), 50% have a buy recommendation. Remaining 50% have either sell or hold recommendations.
The latest share price of Ptc Therapeutics, Inc. (PTCT) is $38.49 as of 12/10/2024.
10 of total 20 analysts offering stock ratings for Ptc Therapeutics, Inc. PTCT have recommended buy rating.
₹0 US Stocks a/c Opening Fee